look wrote:It's in a WHO site.
See, this is part of the problem, you don't have the experience to know what you're talking about. This is not some kind of recommendation from the WHO, it is their library website, with a copy of a paper from the World Journal of Clinical Cases, a fairly minor journal for reporting cases. It only has three patients with no controls - it's anecdote not science.
Yes, these kinds of anecdotes can lead to proper studies, but they're meaningless on their own. Imagine I said that I had three Covid patients who got better after eating hamburgers, would you immediately put all Covid patients on hamburgers? Of course not.
look wrote:for they who will say that this is not cientifical proof, my answer is the same: we are in a war.
War is all about managing resources - direct resources at the wrong target and they will be wasted. Poland had invested lots of money in cavalry in 1939 - an approach which had worked well for hundreds of years, but then they were faced by German tanks.
In this case the scarce resource is health budgets and the facilities to test drugs properly - both are limited and should not be wasted.
look wrote:as almitrine is an old substance, nobody will gave millions to pay for a research like the friends of the virus want.
Nonsense. There's plenty of organisations funding trials of off-patent drugs for Covid, notably the British government with the RECOVERY trial which has saved possibly millions of lives by validating dexamethasone as a treatment for Covid - a classic "cheap" off-patent drug. It's also given answers on what doesn't work, like hydroxychloroquine. Only friends of the virus would want to waste resources on things that don't work.
I really don't get what your point is here - this is a notification that a trial has been approved by an ethics committee - disproving your point that nobody wants to do trials on off=patent drugs!
It doesn't prove that it works. Yes, there is a plausible mechanism by which almitrine might help a subset of Covid patients and it's worth studying it, but no more than that. If it does work then terrific - but at the moment we don't know if it works or not.